Genomics of Drug Sensitivity in Cancer Cabozantinib
Synonyms BMS-907351, XL-184, Cometriq
Targets VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, TIE2,AXL
Target pathway Other, kinases
PubCHEM ID 25102847
Jsmol
Download molecule 25102847
PUBCHEM IUPAC INCHI InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34)
Smiles FC5(=CC=C(NC(=O)C4(C(=O)NC3(=CC=C(OC=1(C=2(C(N=CC=1)=CC(OC)=C(C=2)OC)))C=C3))(CC4))C=C5)
Cluster number 43
calculated LogS -6,978
Molecular weight 501,513
calculated LogP 4,0714
H-Acceptors 8
H-Donors 2
Ro5 violations 1
Druglikeness 0,15767
DrugScore 0,277024249045356
Mutagenic none
Tumorigenic none
Reproductive Effective none
Irritant none
Fish Toxicity High FHMT
Fish Toxicity2 1,0809
Rat Acute Toxicity 2,4789
Acute Oral Toxicity III
Caco-2 Permeability Caco2-
Caco-2 Permeability2 1,1625
P-glycoprotein Substrate Substrate
P-glycoprotein Inhibitor Non-inhibitor
P-glycoprotein Inhibitor2 Non-inhibitor
Human Ether-a-go-go-Related Gene Inhibition Weak inhibitor
Human Ether-a-go-go-Related Gene Inhibition2 Non-inhibitor
Tetrahymena Pyriformis Toxicity High TPT
Tetrahymena Pyriformis Toxicity2 0,7838
AMES Toxicity Non AMES toxic
CYP450 2C9 Substrate Non-substrate
CYP450 3A4 Substrate Substrate
CYP450 3A4 Inhibitor Non-inhibitor
CYP450 2C19 Inhibitor Non-inhibitor
CYP450 2C9 Inhibitor Non-inhibitor
CYP450 2D6 Inhibitor Non-inhibitor
CYP450 1A2 Inhibitor Non-inhibitor
CYP450 2D6 Substrate Non-substrate
Biodegradation Not ready biodegradable
Carcinogenicity (Three-class) Non-carcinogens
Carcinogens Non-required
Blood-Brain Barrier BBB+
CYP Inhibitory Promiscuity High CYP Inhibitory Promiscuity
Honey Bee Toxicity Low HBT
Renal Organic Cation Transporter Non-inhibitor
Subcellular localization Mitochondria
Human Intestinal Absorption HIA+
Aqueous solubility -3,6221
Information useful only for research purposes.